Clinical trial
The Role of the Gut Microbiome in Axial Spondyloarthritis (AxSpA) Disease Activity
NCT04713995 is registered in ClinicalTrials.gov with Viome as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Role of the Gut Microbiome in Axial Spondyloarthritis (AxSpA) Disease Activity
- Lead sponsor
- Viome
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- June 22, 2020
- Completion date
- June 15, 2022
- Enrollment
- 95 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.